Specialized Accessory Devices to Drive US Market Growth
According to a new report by Millennium Research Group (MRG), the US market for accessory devices, comprising percutaneous transluminal coronary angioplasty (PTCA) guidewires, diagnostic catheters, PTCA guiding catheters, intravascular ultrasound (IVUS) catheters, and introducer sheaths, was worth nearly $400 million in 2004 and will exceed $500 million by 2009.
(PRWEB) August 3, 2005 -— The aging US population, which is at heightened
risk for coronary artery disease (CAD), is fueling a growing demand for less
invasive percutaneous coronary intervention (PCI) procedures to treat the
disease. PCI procedure volumes are rising annually, contributing to the
increased use of specific accessory devices required for every PCI procedure.
According to a new report by Millennium Research Group (MRG), the US market for
accessory devices, comprising percutaneous transluminal coronary angioplasty
(PTCA) guidewires, diagnostic catheters, PTCA guiding catheters, intravascular
ultrasound (IVUS) catheters, and introducer sheaths, was worth nearly $400
million in 2004 and will exceed $500 million by 2009.
An increasing
patient population, coupled with escalating demand among physicians for less
invasive and more effective accessory devices, has prompted manufacturers to
develop products for specialized procedures and clinical situations. Specialty
accessories, such as guidewires designed for treatment of chronic total
occlusions, and accessories that incorporate new functionalities such as IVUS
catheters, enable physicians to diagnose and treat CAD more effectively, while
commanding a premium price. The development of specialized products will also
further expand the potential CAD patient pool by enabling physicians to treat
individuals with advanced cases of coronary blockage previously ineligible for a
PCI procedure.
US Markets for Accessory Devices 2005 is part of MRG’s
2005 Marketfocus series, which offers US and European brand- and quarter-level
coverage of coronary stents, PTCA balloons, and accessory devices as well as US
coverage of plaque modification. MRG has also relaunched its Global
Interventional Cardiology series, which features in-depth analysis of IC-related
markets in the US, with forthcoming coverage of Europe, Japan, Latin America,
and Asia Pacific. Global competitive coverage includes Abbott Vascular (ABT),
Boston Scientific (BSX), Cordis (JNJ), Guidant (GDT), and Medtronic (MDT), among
others.
A leading source of competitive intelligence, MRG is now the
largest provider of medical device market research in the world. Located in
Toronto, Canada, MRG covers global markets and has pioneered reporting of
numerous emerging products.
Contact:
Derrick
Navarro
416-364-7776
e-mail protected from spam bots
# # #
Source : http://www.prweb.com/releases/2005/8/prweb266504.htm